JP2008540589A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540589A5
JP2008540589A5 JP2008511587A JP2008511587A JP2008540589A5 JP 2008540589 A5 JP2008540589 A5 JP 2008540589A5 JP 2008511587 A JP2008511587 A JP 2008511587A JP 2008511587 A JP2008511587 A JP 2008511587A JP 2008540589 A5 JP2008540589 A5 JP 2008540589A5
Authority
JP
Japan
Prior art keywords
alkylene
alkyl
unsubstituted
independently
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008511587A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540589A (ja
JP5027802B2 (ja
Filing date
Publication date
Priority claimed from EP05010929A external-priority patent/EP1724269A1/en
Application filed filed Critical
Publication of JP2008540589A publication Critical patent/JP2008540589A/ja
Publication of JP2008540589A5 publication Critical patent/JP2008540589A5/ja
Application granted granted Critical
Publication of JP5027802B2 publication Critical patent/JP5027802B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008511587A 2005-05-20 2006-05-06 第Xa因子阻害剤としてのヘテロアリール−カルボン酸(スルファモイルアルキル)アミド−誘導体 Expired - Fee Related JP5027802B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05010929.7 2005-05-20
EP05010929A EP1724269A1 (en) 2005-05-20 2005-05-20 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
PCT/EP2006/004255 WO2006122661A1 (en) 2005-05-20 2006-05-06 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors

Publications (3)

Publication Number Publication Date
JP2008540589A JP2008540589A (ja) 2008-11-20
JP2008540589A5 true JP2008540589A5 (cg-RX-API-DMAC7.html) 2009-06-25
JP5027802B2 JP5027802B2 (ja) 2012-09-19

Family

ID=35116052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511587A Expired - Fee Related JP5027802B2 (ja) 2005-05-20 2006-05-06 第Xa因子阻害剤としてのヘテロアリール−カルボン酸(スルファモイルアルキル)アミド−誘導体

Country Status (25)

Country Link
US (1) US8088925B2 (cg-RX-API-DMAC7.html)
EP (2) EP1724269A1 (cg-RX-API-DMAC7.html)
JP (1) JP5027802B2 (cg-RX-API-DMAC7.html)
KR (1) KR101373533B1 (cg-RX-API-DMAC7.html)
CN (1) CN101180296B (cg-RX-API-DMAC7.html)
AR (1) AR053730A1 (cg-RX-API-DMAC7.html)
AT (1) ATE452133T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006246669B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0610320A2 (cg-RX-API-DMAC7.html)
CA (1) CA2609288C (cg-RX-API-DMAC7.html)
DE (1) DE602006011156D1 (cg-RX-API-DMAC7.html)
DK (1) DK1888567T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2006000119A (cg-RX-API-DMAC7.html)
ES (1) ES2338151T3 (cg-RX-API-DMAC7.html)
GT (1) GT200600211A (cg-RX-API-DMAC7.html)
IL (1) IL187430A (cg-RX-API-DMAC7.html)
MX (1) MX2007014274A (cg-RX-API-DMAC7.html)
MY (1) MY150693A (cg-RX-API-DMAC7.html)
PA (1) PA8675301A1 (cg-RX-API-DMAC7.html)
PE (1) PE20061452A1 (cg-RX-API-DMAC7.html)
PT (1) PT1888567E (cg-RX-API-DMAC7.html)
SV (1) SV2007002534A (cg-RX-API-DMAC7.html)
TW (1) TWI376377B (cg-RX-API-DMAC7.html)
UY (1) UY29550A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006122661A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012149102A1 (en) * 2011-04-29 2012-11-01 Glaxosmithkline Llc Novel compounds as wip1 inhibitors
EP3078378B1 (en) 2015-04-08 2020-06-24 Vaiomer Use of factor xa inhibitors for regulating glycemia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA953361B (en) 1994-04-26 1996-01-12 Selectide Corp Factor Xa inhibitors
GB0030305D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
EP1217000A1 (en) * 2000-12-23 2002-06-26 Aventis Pharma Deutschland GmbH Inhibitors of factor Xa and factor VIIa
HUP0304058A2 (hu) * 2001-01-30 2004-04-28 Bristol-Myers Squibb Company Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
DE10254336A1 (de) * 2002-11-21 2004-06-03 Merck Patent Gmbh Carbonsäureamide
US7491827B2 (en) * 2002-12-23 2009-02-17 Millennium Pharmaceuticals, Inc. Aryl sulfonamides useful as inhibitors of chemokine receptor activity
AU2003292218A1 (en) * 2002-12-23 2004-07-14 Sanofi-Aventis Deutschland Gmbh PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
EP1590327A1 (en) * 2002-12-23 2005-11-02 Millennium Pharmaceuticals, Inc. Ccr8 inhibitors
EP1479678A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Pyrazole-derivatives as factor xa inhibitors
TW200510311A (en) * 2002-12-23 2005-03-16 Millennium Pharm Inc CCr8 inhibitors
DE10322469A1 (de) * 2003-05-19 2004-12-16 Bayer Healthcare Ag Heterocyclische Verbindungen
US7169795B2 (en) * 2003-09-30 2007-01-30 Bristol Myers Squibb Company Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors

Similar Documents

Publication Publication Date Title
JP2011507916A5 (cg-RX-API-DMAC7.html)
JP2010523605A5 (cg-RX-API-DMAC7.html)
JP2009509989A5 (cg-RX-API-DMAC7.html)
JP6262228B2 (ja) RORcモジュレーターとしてのアリールスルタム誘導体
CA2590939C (en) Aminopyrimidine compounds and methods of use
JP2011512368A5 (cg-RX-API-DMAC7.html)
ES2392758T3 (es) 4,5,6,7-Tetrahidrotienopiridinas sustituidas como moduladores de KCNQ2/3 para el tratamiento del dolor, la epilepsia y la incontinencia urinaria
ES2821896T3 (es) Antagonistas del receptor de dopamina D3 que tienen una unidad estructural biciclo
AU2009217075B2 (en) Chlorothiophene-amides as inhibitors of coagulation factors Xa and thrombin
AU2005219507A1 (en) Pyrrole-derivatives as factor Xa inhibitors
CA2526082A1 (en) Triazole-derivatives as factor xa inhibitors
JP2006528213A5 (cg-RX-API-DMAC7.html)
JP2011512367A5 (cg-RX-API-DMAC7.html)
JP2006528214A5 (cg-RX-API-DMAC7.html)
RU2005139555A (ru) Производные бензимидазола в качестве ингибиторов фактора ха
ES2839407T3 (es) Antagonistas del receptor de dopamina D3 que tienen una unidad estructural morfolina
RU2005139557A (ru) Азаиндольные производные в качестве ингибиторов фактора ха
JP5422569B2 (ja) 凝固第Xa因子及びトロンビンの阻害剤としてのクロロチオフェン−イソオキサゾール類
ES2313371T3 (es) Derivados de piridoindolona sustituidos en -6, su preparacion, su aplicacion en terapeutica.
ES2338151T3 (es) Derivados de (sulfamoil alquil) amida del acido heteroaril-carboxilico como inhibidores del factor xa.
JP2008527013A5 (cg-RX-API-DMAC7.html)
TH71667A (th) อนุพันธ์เบนซิมิดาโซลในฐานะสารยับยั้งแฟกเตอร์ Xa
ME02844B (me) Jedinjenja i kompozicije za modulaciju aktivnosti egfr